Fmoc-alpha-Me-D-Pro-OH

Fmoc-alpha-Me-D-Pro-OH is a D-proline derivative bearing an N-(9H-fluoren-9-ylmethoxycarbonyl) (Fmoc) protecting group and an alpha-methyl substituent, giving a conformationally constrained, chiral amino acid building block for peptide chemistry. The molecule contains a tertiary stereogenic center at the alpha carbon (bearing the methyl group) and the proline ring stereochemistry associated with the D configuration, while retaining a carboxylic acid for C-terminal coupling or further derivatization. The Fmoc carbamate provides base-labile protection of the secondary amine, enabling standard solid-phase or solution-phase peptide assembly workflows. The combination of the cyclic proline scaffold and alpha-methyl substitution influences backbone dihedral preferences and can affect coupling behavior, side-chain reactivity patterns, and downstream peptidomimetic design.

1. Peptide Synthesis

Fmoc-alpha-Me-D-Pro-OH is used in peptide building workflows where Fmoc deprotection and subsequent amide bond formation require a stable N-protected amino acid with a free carboxyl group. The proline ring functions as a rigid secondary amine-containing residue that participates in peptide bond formation while limiting conformational freedom, and the alpha-methyl substituent can bias local backbone geometry in the growing chain. The D stereochemistry and the defined alpha-methyl stereocenter enable stereochemically controlled incorporation into peptides and peptide analogs, including sequences that require non-proteinogenic stereochemical patterns. The resulting product is suitable for constructing peptide libraries, cyclic or constrained motifs, and research-grade peptide intermediates that depend on reliable Fmoc chemistry.

2. Peptidomimetics And SAR

Fmoc-alpha-Me-D-Pro-OH serves in peptidomimetic and structure-activity relationship studies where proline-based conformational restriction and alpha-methyl substitution can modulate turn formation, helicity propensity, and binding-site fit. The Fmoc-protected amine allows controlled incorporation into analogs during iterative synthesis, while the carboxylic acid enables further functional transformations such as conversion to amides, esters, or activated derivatives for scaffold diversification. The dual stereochemical definition (D proline configuration and alpha-methyl stereocenter) supports systematic SAR exploration of stereochemical effects on molecular recognition. Downstream derivatives prepared from this chiral amino acid intermediate can be used to generate constrained peptide mimics and to support comparative studies of analog series in medicinal chemistry research.

3. Side-Chain Functionalization

Fmoc-alpha-Me-D-Pro-OH is applied in amino acid derivatization strategies where the carboxylic acid and the protected nitrogen enable staged chemical modification without premature loss of the Fmoc group. The proline ring provides a secondary amide-forming nitrogen within the peptide context, while the alpha-methyl substituent introduces a hydrophobic handle that can influence reactivity and steric environment during subsequent coupling or functional group installation. The Fmoc carbamate can be removed under base conditions to expose the amine for targeted conjugation, while retaining the carboxyl group for orthogonal activation and coupling. Functionalized derivatives derived from this chiral intermediate can be used to access backbone-modified analogs, linker-bearing constructs, and intermediate structures for further synthetic elaboration.

4. Chemical Biology Conjugation

Fmoc-alpha-Me-D-Pro-OH is suitable for chemical biology workflows that require stereochemically defined peptide segments for labeling, affinity reagents, or biomolecule-targeting probes. The Fmoc-protected amine supports stepwise assembly of defined peptide motifs, and the carboxylic acid can be transformed into activated intermediates for conjugation handles or for incorporation into larger constructs. The D configuration and alpha-methyl substitution can help tune protease stability and conformational presentation of the peptide region used in binding assays or probe generation. Downstream conjugation-ready peptide fragments prepared from this amino acid derivative can be employed to build defined molecular scaffolds for studying biomolecular interactions and for generating research-grade labeling reagents.

5. Pharmaceutical Intermediate Preparation

Fmoc-alpha-Me-D-Pro-OH is used in pharmaceutical intermediate preparation where controlled stereochemistry and protected-amino-acid handling are required for manufacturing-relevant peptide building blocks. The Fmoc carbamate provides a robust N-protection strategy compatible with common peptide coupling chemistries, while the free carboxylic acid supports conversion to activated forms for incorporation into longer sequences or for producing defined peptide intermediates. The proline scaffold and alpha-methyl substitution can contribute to consistent synthesis of constrained peptide fragments used in process routes for peptidic drug candidates and related research materials. The compound's defined stereochemical identity makes it suitable for reproducible intermediate generation in fine chemical synthesis and applied peptide manufacturing workflows.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. TMEM16F and dynamins control expansive plasma membrane reservoirs

3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

4. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

5. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef